Satratoxin H

Urinary satratoxin H is a research-stage measurement. Published evidence has not established how a result relates to the dose you absorbed, the building where exposure occurred, or the cause of your symptoms. This catalog reports an individual toxin in urine, but it does not specify the analytical method. Studies of broader toxin groups do not validate this specific measurement. Clinical evidence assessment.

A Toxin From Wet Building Materials

Satratoxin H belongs to a group of chemically related mold toxins called macrocyclic trichothecenes. Some strains of Stachybotrys chartarum produce these toxins; others do not. The mold can grow on paper, wallboard, and other materials that remain wet. Its dark color cannot show whether a particular patch is producing toxins. Fungal strain research, CDC mold information.

In a laboratory experiment, satratoxin H was the most abundant of four toxins measured when a toxin-producing strain grew on several building materials, including wallpaper. That finding describes the strain and conditions studied. Satratoxins G and H have also been identified in air sampled from a water-damaged dwelling, which supports the possibility of inhalation exposure. Neither study measured the occupants' urine or established a relationship between an air concentration and a urine result. Building-material experiment, indoor-air study.

What the Urine Number Means

The reported unit is ng/g creatinine. The laboratory divides the measured toxin concentration by the urine creatinine concentration to reduce the effect of dilution. Creatinine is a waste product related to muscle metabolism. This adjustment does not establish how much toxin is stored in your body or whether the amount detected is harmful. Research on urine concentration adjustment is general measurement evidence, not validation of satratoxin H testing. Urinary creatinine study.

Human absorption and urinary excretion of satratoxin H remain poorly characterized. There is no established detection window or reliable way to date an exposure from the result. A New Zealand government-commissioned assessment found commercial urine testing but no published human excretion data for this molecule. Clearance findings for other trichothecenes cannot supply the missing information. Exposure assessment.

What Human Studies Show

Damp buildings are associated with cough, wheezing, and the development or worsening of asthma. Those health effects deserve attention even though urinary satratoxin H has no established role in diagnosing them. The American College of Medical Toxicology treats toxin-producing mold and actual toxin exposure as separate questions. It also notes that modeled inhaled toxin doses in moldy buildings are typically far below levels that cause harm in toxicology studies. NIOSH health evidence, Medical toxicology assessment.

In a 1996 study, employees who had worked in a water-damaged office for a mean of 3.1 years reported more breathing, skin, eye, and fatigue symptoms than controls. The study also found a lower proportion of T cells in their blood. T cells are part of your immune defenses. The investigators examined building contamination and workers' health; they did not measure urinary satratoxin H. Exposure involved several fungi, so the findings cannot isolate this toxin as the cause or establish a urine marker of immune impairment. Office-worker study.

A 2013 study tested 112 people with chronic fatigue syndrome and reported detectable mycotoxins in most participants. Its trichothecene assay measured a toxin group, not satratoxin H separately. It used previously reported healthy controls and could not establish that mold toxins caused the illness or came from a particular building. Chronic-fatigue study.

Laboratory Findings and Their Limits

Experiments with isolated rat and mouse cells found that satratoxin H interfered with protein production and cell growth. These findings establish biological toxicity under the experimental conditions, without defining a harmful urine level in people. Some often-cited experiments on damage to smell-related nerves in the nose and brain used satratoxin G in mice. That is a different toxin and an animal model, so those findings cannot establish brain injury from a urinary satratoxin H result. Cell experiments, mouse study.

A proposed connection between Stachybotrys chartarum and unexplained lung bleeding in infants has not been proven. Urinary satratoxin H has no validated role in identifying that condition. CDC assessment.

How Well the Urine Test Performs

A frequently cited 2009 study used an antibody assay for macrocyclic trichothecenes. Its validation work included samples spiked with satratoxin H, but this did not make the assay specific to that molecule. The authors described qualitative validation and reported separate accuracy estimates for urine, nasal secretions, and tissue. Those estimates were not established against an independent standard confirming individual satratoxin H exposure and cannot be applied to the creatinine-adjusted result offered here. The study also does not establish urine as the best specimen for detecting satratoxin H specifically. Original assay study.

When Results Can Be Misleading

• Unspecified method: the catalog does not establish whether the laboratory distinguishes satratoxin H from related toxins. An antibody response to a toxin family cannot be interpreted as confirmed detection of one member.
• Urine dilution and creatinine: hydration, muscle mass, age, and kidney function can affect the creatinine adjustment. A change in the ratio may partly reflect changes in creatinine. These are general limitations of urine biomonitoring. Creatinine study.
• Unknown timing: the result cannot reliably distinguish recent exposure from earlier exposure because human excretion has not been adequately characterized.
• Clinical interpretation: a laboratory flag or detection limit is not a validated threshold for illness. A negative result also cannot establish that a building is safe or exclude mold-related allergy or asthma. CDC urine-testing assessment.

What Serial Results Can Establish

There is no validated size of change that indicates recovery, successful remediation, or a change in disease risk. Repeating the same measurement does not resolve uncertainty about what it represents. Comparisons are further limited when laboratories, methods, or collection conditions differ.